Medi-Physics' Ceretec imaging agent launching in mid-June for detecting infections.
This article was originally published in The Gray Sheet
Executive Summary
MEDI-PHYSICS' CERETEC NEW FORMULATION WILL BE LAUNCHED at the Society of Nuclear Medicine's annual meeting June 12-15 in Minneapolis. Three improvements of the diagnostic imaging agent Ceretec (technetium Tc99m exametazime) were approved April 7 through two efficacy supplements.